Invitae, a medical genetic testing company, has filed for Chapter 11 bankruptcy and intends to continue the case without disrupting operations using cash on hand and while seeking to sell its business.
The San Francisco-based company is seeking approval from the U.S. Bankruptcy Court for the District of New Jersey to use its cash on hand to fund the case.
In its bankruptcy petition, the...
Medical genetic testing company Invitae announced Tuesday it had signed a definitive agreement to acquire Ciitizen, a startup that helps users access and organize their health records, for about $325 million.
The terms of the deal include around $125 million in cash and approximately 7,070,000 shares of Invitae common stock. Invitae will also issue about $226 million restricted stock units to new...
Personal genomics startup Helix, which is developing a digital hub for all things related to DNA testing ranging from direct-to-consumer to doctor-ordered, has announced several partnerships: the Icahn School of Medicine at Mount Sinai, National Geographic and ExploraGen will collaborate to deploy Helix’s genetic-testing service, which is powered by DNA sequencing giant Illumina. Additionally,...
